NDC 15631-0591

GLONOINUM

Glonoinum

GLONOINUM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Nitroglycerin.

Product ID15631-0591_af0e5103-4345-480e-809e-771148175a71
NDC15631-0591
Product TypeHuman Otc Drug
Proprietary NameGLONOINUM
Generic NameGlonoinum
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-01-07
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameNITROGLYCERIN
Active Ingredient Strength6 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0591-7

10000 TABLET in 1 CONTAINER (15631-0591-7)
Marketing Start Date2016-01-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0591-3 [15631059103]

GLONOINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-07
Inactivation Date2020-01-31

NDC 15631-0591-5 [15631059105]

GLONOINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-07
Inactivation Date2020-01-31

NDC 15631-0591-6 [15631059106]

GLONOINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-07
Inactivation Date2020-01-31

NDC 15631-0591-7 [15631059107]

GLONOINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-07
Inactivation Date2020-01-31

NDC 15631-0591-0 [15631059100]

GLONOINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-07
Inactivation Date2020-01-31

NDC 15631-0591-1 [15631059101]

GLONOINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-07
Inactivation Date2020-01-31

NDC 15631-0591-4 [15631059104]

GLONOINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-07
Inactivation Date2020-01-31

NDC 15631-0591-2 [15631059102]

GLONOINUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-07
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
NITROGLYCERIN6 [hp_X]/1

OpenFDA Data

SPL SET ID:76fa87ad-cc28-4af9-8c43-d442e2abd112
Manufacturer
UNII
UPC Code
  • 8907460005526
  • NDC Crossover Matching brand name "GLONOINUM" or generic name "Glonoinum"

    NDCBrand NameGeneric Name
    0220-2279GlonoinumNITROGLYCERIN
    0220-2282GlonoinumNITROGLYCERIN
    0220-2283GlonoinumNITROGLYCERIN
    0220-2286GlonoinumNITROGLYCERIN
    0220-2287GlonoinumNITROGLYCERIN
    0220-2290GlonoinumNITROGLYCERIN
    0220-2291GlonoinumNITROGLYCERIN
    0220-2293GlonoinumNITROGLYCERIN
    15631-0207GLONOINUMGLONOINUM
    15631-0591GLONOINUMGLONOINUM
    37662-1647GlonoinumGlonoinum
    37662-1648GlonoinumGlonoinum
    37662-1649GlonoinumGlonoinum
    37662-1650GlonoinumGlonoinum
    37662-1651GlonoinumGlonoinum
    37662-1652GlonoinumGlonoinum
    37662-1653GlonoinumGlonoinum
    37662-1654GlonoinumGlonoinum
    37662-1655GlonoinumGlonoinum
    60512-6281GLONOINUMGLONOINUM
    62106-5945GLONOINUMGlyceryl trinitrate
    68428-407GlonoinumNITROGLYCERIN
    71919-318GlonoinumNITROGLYCERIN

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.